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SAMMANFATTNING 
Skador på gaffelbandet är ett stort problem inom hästvärlden och framförallt inom ridsporten. 
Eftersom många tävlingshästar drabbas finns idag höga krav på veterinärer inom både 
diagnostik och behandling för att göra de drabbade hästarna friska igen. Då gaffelbandet är en 
svårläkt struktur så finns ännu ingen revolutionerande behandling att tillgå för att optimera 
läkning. Detta har medfört att flera olika behandlingar testas och används för att komma 
närmare en konsensus för skadan. Då man som veterinär rekommenderar behandling och 
förebyggande åtgärder är det viktigt att man är medveten om varför gaffelbandet går sönder 
och även vad som händer under läkningsprocessen. Behandlingen går ut på att minska den 
akuta inflammation som sker direkt efter skada, för att senare underlätta för återuppbyggnad 
av gaffelbandets struktur. Man vill dessutom hindra bildning av ärrvävnad som predisponerar 
för ytterligare skador då den saknar samma styrka och elasticitet som frisk vävnad. 
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SUMMARY 
Injuries to the suspensory ligament represent a huge problem in equine veterinary medicine. 
As many of the affected horses are elite-competition athletes, there are high expectations on 
veterinarians to make these horses fully functional again.  
 
The suspensory ligament has several features which makes the healing process complicated. 
So far no treatment has shown to optimize the healing process. This has led to the testing of 
many new treatment methods, in order to find a consensus for the injury. When 
recommending treatments and preventing factors to hinder injuries to the suspensory 
ligament, it is important to know why the particular ligament has been ruptured. It is also 
important to study exactly what happens during the healing process.  
 
Existing treatments aim at minimizing the acute inflammation that occurs directly after the 
injury and then ease the process of regaining the structure of the ligament tissue. The aim is 
also to prevent scar tissue from forming and becoming abundant. The reason for this is that 
scar tissue lacks the strength and elasticity of the healthy ligament tissue.  
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INTRODUCTION 
Suspensory ligament injuries are common reasons for why sport horses become lame and put 
off training. A study from 2009 in Great Britain shows that it was the second most common 
injury for dressage horses (Murray et al., 2009). Injuries to the suspensory ligament are of 
special interest since many of the affected horses are elite-competition athletes and expected 
to reach the same level of performance as before the injury. Therefore, there are high 
expectations on veterinarians to make horses with ligament injuries fully recovered. 
Moreover, owners expect that their injured horse will be treated, even if there is little research 
and documented evidence of the treatment methods at hand.   
 
Different methods of how to treat suspensory ligament injuries are a hot topic in equine 
veterinary medicine. Several new methods have been described in recent years. The question 
of how these methods work in relation to what actually happens when the suspensory 
ligament is broken down and rebuilt, is however not clear. It is important that veterinarians 
understand the pathobiology of the injury and also what different treatments are aimed at to 
optimize healing.  
 
This essay will illustrate the pathogenesis and the healing process of a damaged suspensory 
ligament. It will also present how some of the most common treatments could improve 
healing. 
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MATERIALS AND METHODS 
The study is based on scientific papers, studies and publications relevant to the topic. The 
following web sites were used for finding the reports: 
 
1. http://www.pubmed.com 
2. http://www.sciencedirect.com 
3. scholar.google.com 
 
The phrases used for search were “suspensory ligament injuries”, “treatment of suspensory 
ligament injuries” and “diagnostic methods”. These phrases were combined with “equine 
AND + OR horse”. The library at the Swedish University of Agricultural Sciences was also 
used; to find publications and books describing the anatomy of the suspensory ligament and to 
acquire useful information about different diagnostic techniques.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
LITTERATURE REVIEW 
Anatomy, function and composition of the suspensory ligament 
The suspensory ligament, or the interosseous muscle, is a strong tendinous band. It arises 
from the proximal end of the third metacarpal bone (MCIII) and the distal row of the carpal 
bones in the front limbs. In the hind limbs it arises from the proximal end of the third 
metatarsal bone (MTIII) and the distal row of the tarsal bones. 
 
The ligament lies deep to the flexor tendons between the second and fourth metacarpal bones. 
It has one surface towards the MCIII/MTIII and the other surface towards the flexor tendons 
and divides into two branches that attach to the proximal sesamoid bones. The branches give 
rise to a medial and a lateral band, both extending to the common digital extensor tendon on 
the dorsal end of the foot. 
 
The suspensory ligament is usually divided into three parts: the proximal part where the 
ligament originates, the body of the ligament which lies along the third metacarpal bone and 
the lower branches of the ligament, that insert into the sesamoid bones.  
 
 
 
 
Figure illustrated by Stina Qvarnström (Copyright © Equiart) shows a simplified version of 
how the tendons in the horse are located. Note that the extension of the two branches of the 
suspensory ligament to the common digital extensor tendon is not visible. 1.  Superficial 
flexor tendon 2. Suspensory ligament 3. Deep flexor tendon 4. Common digital extensor 
tendon. 
 
The function of the ligament is to provide support for the proximal fetlock joint. It prevents 
the fetlock joint from excessive dorsal flexion and also limits the palmar flexion of the joint 
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because of the branches stretching to the common digital extensor muscle. Furthermore, it 
helps to minimize concussion (König & Liebich, 2007). 
 
The suspensory ligament has tendinous features even though it differs a bit in composition, 
compared to the other flexor tendons (Zousa et al., 2010). It is referred to as neither a tendon 
nor a muscle, but a complex ligamentous structure that originates from a muscle through 
evolution (Soffler & Hermansson, 2006). 
 
The suspensory ligament is composed of nearly 70% water and 30% dry mass (Dowling et al., 
2000). The dry mass contains fibroblasts and tendon specific tenocytes which are arranged 
along the length of the tendon (Soffler& Hermansson, 2006). The tenocytes produce the 
extracellular matrix (ECM), which is characterized by connective tissue with collagen, 
proteoglycans, glycoproteins, glycosaminoglycanes and vascularized zones (Dowling et al., 
2000). The dry mass also contains about 10% muscle fibers (Soffler& Hermansson, 2006), 
and between those adipose tissue can be found (Cunningham, 1883). 
 
About 85% of collagen is collagen I and the remainder collagen III. Collagen I fibrils are 
strictly organized in fibers that form a parallel pattern and makes it possible for the tendon to 
attach to the bone. Collagen III is mainly present in scar tissue and lacks the strength and 
elasticity of collagen I (Soffler& Hermansson, 2006). The ligament seems to have more 
collagen III than other tendinous structures and also a higher frequency of 
glycosaminoglycanes. The fibroblasts have shown to have a more narrow appearance than the 
tenocytes, which makes it a complex ligamentous structure (Zouza et al., 2010). 
 
Injuries to the suspensory ligament 
Injuries to the suspensory ligament can differ in severity depending on where the injury is 
located, and also how severe the damage is. Predominantly the injury is located on the first 
proximal third of the ligament, which gives rise to proximal suspensory desmitis (PSD). This 
is an inflammation of the proximal aspect of the suspensory ligament. However, desmitis can 
also arise in the body or branches of the suspensory ligament. When an injury has occurred, 
horses are usually more lame on soft ground than on hard ground since the suspensory 
ligament then is more loaded (Dyson, 2007). 
Acute injury 
A common reason for an injury is overstretching the ligament, usually through hyperflexion 
of the metacarpal/metatarsal joint (Murray et al., 2009), leading to a single overload of the 
ligament and a rupture of the collagen fibers. There is however a contradiction to whether 
these injuries have undergone a gradual breakdown of ECM, which predisposes for a single 
overload, or if it is a single overstretch that is responsible for the injury. 
Degenerative injury 
If the ligament is gradually broken down, the injury is referred to as degenerative suspensory 
ligament disease (DSLD) or “overuse injury”. This happens when the repetitive nature of 
loads on the tendon creates damages to ECM at a higher rate than the cells within the tendon 
can repair. Overstimulation has shown to increase inflammatory cytokines and destructive 
enzymes, which contribute to damage that accumulates and finally reach a level that gives 
clinical signs. However, also to less stimulation has indicated catabolic gene expressions that 
contribute to degradation of ECM and loss of function (Dahlgren, 2007). 
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In degenerative injuries, fibrils are reformed into larger bundles with fibroblasts in the middle. 
This hinders the blood supply of the fibroblasts that either die or become chondrocytes who 
try to heal the damage by producing more cartilage-like scar tissue (weak and inelastic) 
instead of collagen I (strong and elastic). This is likely to predispose for new injuries because 
of lost elasticity and strength. It also explains why the risk of repeated injuries is high. If the 
injury reaches a chronic form, oedema is often present and characterized by fibrous tissue, 
which thickens the ligament and gives rise to enlargements (Gibson & Steel, 2002). 
Bone-related traumas and other reasons for injury 
Injuries to the suspensory ligament can also arise through percussion, cutting or a bone-
related trauma, e.g. avulsion fractures. These are small fractures in the bones which create 
uneven areas and bone fragments that disturb the suspensory apparatus (Gibson & Steel, 
2002).  Injuries have also shown to occur due to stress fractures, exostoses and uneven areas 
on MCIII/MTIII, which are rubbing against the ligament and create a secondary desmitis 
(Dyson, 2007). 
 
Pathobiology of injury and repair 
The pathobiology can be divided into three phases; first an acute inflammation phase, second 
a proliferation phase and last the remodeling phase. 
 
1. The inflammation phase usually last 1-2 weeks and is characterized by heat, swelling 
of the area, pain on palpation and immigration of inflammatory cells (Dahlgren, 2007). 
Phagocytes clean up the area, fibroblast produces scar tissue and broken collagen 
fibrils and blood vessels give rise to small hematomas within the ligament (Soffler & 
Hermansson, 2006). A release of vasoactive and chemotactic factors initiate 
angiogenesis, stimulate cell-proliferation and also contributes to recruitment of cells 
involved in wound reparation. There is also an increase of growth-factors and 
inflammatory cytokines (Dahlgren, 2007). 
 
 
2. The proliferation phase usually starts a few days after the injury and can last up to a 
few months. The endotenon (the space between collagen fibrils) is hypertrophied and a 
massive cell invasion can be seen. Many of the cells are low differentiated, 
presumably progenitor cells, but there are also fibroblasts which change their 
morphology and becomes bigger. Tenocytes get an increased gene-expression of 
collagen I and collagen III, and collagen III becomes more abundant in the tissue than 
collagen I. New ECM starts to form and the area becomes hypercellular. After about 4 
weeks, fibrous tissue and granulation-tissue are starting to form and ECM is organized 
into a random pattern. At this level of healing the ligament can only withstand 
minimal exercise (Dahlgren, 2007). 
 
3. The remodeling phase starts about six weeks after the injury and can continue for six 
months or sometimes even 12 months. It is the most critical phase if the horse should 
be able to return to full work again (Dahlgren, 2007). The scar tissue formed in the 
earlier phases of the injury is not comparable to the collagen I fibers that were present 
before the injury and seems to consist of mostly collagen III fibers, which are not fully 
organized. In this phase, the fibers seem to adapt and get a more linear structure along 
the tendon, even though the strength and elasticity will not reach the same level as 
before the injury (Gibson & Steel. 2002). 
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The healing process was long thought to be similar to that of the other tendons but 
ultrasonographic pictures show that the suspensory ligament does not heal as well as the other 
tendons. It also shows more persistent hypoechoic areas, periligamentous soft tissue fibrosis, 
hyperechoic scar tissue and calcification. These findings can be seen both during and after the 
healing process (Soffler & Hermansson, 2006).  
 
Differential diagnoses for suspensory ligament injuries could be desmitis of the accessory 
ligament of the deep digital flexor tendon, carpometacarpal/tarsometatarsal joint pain, and 
also palmar/plantar cortical fatigue fractures of MCIII/MTIII (Dyson, 2007).   
 
The prognosis is said to be better on the front limbs than on the hind limbs and several factors 
have to be considered when judging the severity and prognosis of the injury. Acute injuries 
have also shown to have better prognosis than chronic injuries with degeneration of the 
ligament (Dyson, 2007).  
 
In a clinical study by Dyson (2007), almost 90% of horses went back to full work within three 
months. However, chronic disease and injury of the hindlimbs seem to be more challenging. 
In the same study, horses with proximal injury of the hindlimbs, only 14% (6 of 42) went 
back to full work within one year, all of which had been lame for less than five weeks. 
 
Treatments 
There are several methods in use for treating suspensory ligament injuries, some of which will 
be mentioned in this study. However, none of the methods have alone shown any remarkable 
results in healing blinded and double-blinded studies (Herthel, 2001). 
 
The purpose of a chosen treatment is however to minimize muscle and skeletal pain, provide 
support for the suspensory apparatus (Halper et al., 2010) and maximize collagen I formation 
and organization. It is also desirable to minimize scar tissue (Sutter, 2007) and stimulate new 
ECM formation and organization (Dahlgren, 2007). 
Conservative treatment 
By a so called conservative treatment the horse gets box-rest and controlled walking exercise, 
usually for several months. This treatment is the most used and is often combined with 
clinical, ultrasonographical and radiographical controls, for monitoring the healing process 
(Dyson, 2007). Dahlgren (2007) also emphasizes that the rehabilitation program must match 
the healing phase of the ligament. 
NSAID and Glucocorticoids /Antiinflammatory drugs 
NSAID and Glucocorticoids can be used in the acute phase of an injury to reduce 
inflammation (Gibson & Steel, 2002) and swelling - to minimize the risk of compartment 
syndrome (Dyson, 2007). Compartment syndrome is the compression of blood vessels, 
muscles and nerves inside a closed compartment.  
Cell therapy 
The idea of cell therapy is to make cells differentiate into mature fibroblasts capable of 
building new ECM, as well as producing growth-factors and cytokines (Dahlgren, 2007). 
 
Mesenchymal stem cells (MSC), and other bone marrow components for injection, seem 
promising for the future, according to Sutter (2007). The idea of this technique is that the cells 
can differentiate into tendon-specific fibroblasts at the injured site, and create the appropriate 
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wound matrix. Sutter claims that horses have more connective tissue progenitors in their bone 
marrow aspirate than humans, which would make them even better candidates for surgery. 
 
In a retrospective study by Herthel (2001) on 100 horses, 92% of the candidates returned to 
full work after surgery, compared to 15,6%  of 66 horses that were not treated. Sutter (2007) 
thus concludes that more research must be done and that the expectations are speculative at 
best. Herthel also points out that there can be a risk of damaging the ligament because of the 
large volume of fat cells and bone spicules commonly found in bone aspirate. Bone marrow 
contamination of blood has also been discussed as a risk factor.  
Platelet rich plasma (PRP) 
The idea of injecting PRP to injured tendons and ligaments is to produce a scaffold in the 
form of a fibrin-clot that forms and infuses growth factors into the lesion (Dahlgren, 2007). 
This method has become popular in recent years, especially in the USA (Sutter, 2007). 
 
It is the high concentration of growth factors PDGF, TGF-b, FGF, VEGF, IGF-I and EGF, 
released from platelet a-granules that make PRP especially interesting for tendon and 
ligament healing (McCarrel & Fortier, 2008).  
 
PRP has shown to provide a provisional matrix which increase collagen I production, 
tenocyteproliferation, neovascularization, and also increase early strength, organization and 
fiber pattern alignment (Sutter, 2007).  
 
 Mc Carrel & Fortier (2008) compared the temporal release of growth-factors from PRP, Bone 
marrow aspirate (BMA) and lyophilized platelet product (PP) in vitro. Their results support 
further in vivo investigation of PRP for treatment of tendonitis and desmitis. 
 
Waselau et al, (2008) investigated the outcome of 9 standard breed race-horses with moderate 
to severe mid-body suspensory ligament desmitis (MSD). The horses were treated with one 
intralesional injection of PRP and a gradually increased exercise program. All 9 horses 
returned to race and the authors conclude that the treatment have an excellent prognosis for 
that.   
Acellular urinary bladder matrix (UBM) 
UBM is a lyophilized (freeze-dried) powder, derived from the extracellular matrix of the 
basement membrane of swine urinary bladders. It is non-cellular, but believed to recruit 
growth factors and regenerative cells from the circulatory system and other tissues - and 
differentiate into new healthy tissue (Wallis et al., 2010).  
 
UBM has shown to increase angiogenesis in other species (not specified by the author) 5-7 
days after injection. Other benefits could be providing a scaffold for collagen deposition, 
recruiting new growth-factors to the site and minimizing excessive fibrous tissue formation 
(Wallis et al., 2010). 
 
 According to Dahlgren (2007) it could theoretically provide a scaffold for cellular migration 
into the lesion, and also help organize ECM. Accompanying bioactive molecules could also 
stimulate cell recruitment. 
 
 A study by Wallis et al. (2010) on collagenase induced suspensory ligament injuries thus 
showed that there were no histological differences between the group treated with UBM and 
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the control group. However, there was a trend towards milder lameness for the treated group, 
compared to the control group.  
Shock-wave therapy 
Shock-wave therapy involves pulse acoustic pressure waves sent to a specific area. The 
pressure waves generate high stress forces that act upon cellular interfaces. The treatment 
seems to relieve pain and stimulate healing. However its mechanisms are poorly understood 
(Gibson & Steel, 2002). According to Dyson (2007) shock-wave therapy, or radial pressure 
wave therapy, is useful in some cases, although the results are not guaranteed.  
 
In a study of 16 horses with proximal suspensory desmitis or a similar pain by Imobdem et 
al., (2007), the authors concluded that one session with shock-wave treatment did not ease 
lameness, even though it could not be excluded in certain individuals.  
 
Several authors refer to a study by Chen et al. (2003) which shows that shock-wave 
treatments promoted healing of collagenase induced achilles-tendinitis of rats by inducing 
growth factors TGF-b1 and IGF-1. These growth-factors showed to play an important role in 
cell-proliferation and tissue regeneration in the treated tendons.  
Neuroectomy 
Removal of the deep branch of the lateral plantar nerve has become a routinely used method 
of treating lameness caused by PSD (Pauwels et al., 2009). In a study series of two, made by 
Dyson and Genovese (2003), 5/6 and 8/9 horses went back to 100% performance.  
 
In a study by Kelly (2003), 78/84 (91%) horses went back to full performance. The study by 
Pauwels et al. (2009) showed that neuroectomy of the deep branch of the lateral plantar nerve 
could cause neurogenic atrophy of the muscle fibers in proximal parts of the suspensory 
ligament. Dyson (2007) mentions anecdotal reports of ulnar neurectomy or neurectomy of the 
lateral palmar nerve for management of PSD, but states that she has no personal experience of 
the results. 
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DISCUSSION 
When looking at the anatomy of the suspensory ligament it is understandable that the area is 
subject to great loads of physical pressure in a horse. The suspensory ligament has to provide 
support for the proximal fetlock joint and prevent it from excessive dorsal flexion. At the 
same time it has to hinder palmar flexion.  
 
Since healthy tissue mainly consists of collagen I fibers, elastic and strictly organized, this 
composition is desirable. As the goal with treatment is to regain a healthy tissue, the treatment 
must aim at getting back the strength and elasticity found in collagen I fibers. Therefore, scar 
tissue containing the weaker and more inelastic collagen III must be hindered. 
 
As the repetitive nature of loads on the tendon creates damage to the ECM, the cells in the 
tendon must be able to repair the tissue with the same speed as it is broken down (Dahlgren, 
2007). If not, injuries will arise and scar tissue, containing more collagen III than healthy 
tissue, is created. Since Collagen III lacks the same elasticity and strength as Collagen I, the 
maximum load on the tendon is more rapidly reached.  
 
When discussing degenerative injuries it should be considered that a micro damage, without 
clinical signs, could develop into a larger injury. As the micro damage tries to heal, minimal 
scar tissue forms which weakens the ligament at the injured site. This predispose for new 
injuries.  
 
Since there are three phases of injury and repair, which all are characterized by different 
happenings, it should be considered that the ligament is in favor of different treatments during 
different phases of healing. Alternatively, some treatments could be more successful than 
others, depending on in what phase of healing the ligament is. However, Dyson (2007) 
concludes that most studies made on treatments have lacked control groups. 
 
NSAID and Glucocorticoids can be used in the acute phase of an injury, to reduce 
inflammation and swelling - and minimize the risk of compartment syndrome (Dyson, 2007). 
As the first phase of healing is the inflammation phase with heat, pain and swelling 
(Dahlgren, 2007), one could understand that the risk of compartment syndrome increase, and 
also that this phase of injury should be controlled. 
  
During the proliferation phase a massive cell invasion can be seen. Collagen I and III get an 
increased gene expression and new ECM starts to form. This phase goes together with the 
remodeling phase, which is the most critical phase according to Dahlberg (2007). This is due 
to the fact that the remodeling of scar tissue, to a more organized and elastic tissue, becomes 
evident and that this step often fails. It is therefore in this phase of healing that most 
treatments are designed to improve effective healing. 
 
Cell therapy is built on the idea that mesenchymal stem-cells differentiate into mature 
fibroblasts, capable of producing new ECM. Growth-factors and cytokines should also be 
produced to – so far in theory - boost healing. If applied during the healing phase, the idea 
seems very promising, also concluded by Sutter (2007). However, just like many other 
techniques used for tendon and ligament healing, this method lacks placebo-controlled 
studies, even though there are some interesting in-vitro studies made (Sutter, 2007). 
 
In the retrospective study by Herthel (2001), 92% of the candidates returned to full work. 
However, some important information was missing. For example, lameness duration, 
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location, lesion size and hind limb versus front limb were not fully declared. This lack of 
input makes it hard to evaluate the study. It seems that Sutters (2007) conclusion of more 
research, instead of speculations, is relevant in this case, even if the method seems promising. 
It is also important to consider the risks that are associated with collecting bone-marrow 
aspirate and injecting into tendons. Sutter (2007) mentions secondary injuries by bone 
spicules as a possible negative consequence. Even if stem cells are favorable for healing 
ligament injuries, the risk of creating a secondary damage should always be considered when 
choosing a treatment. If the risk of secondary damage is big there is also a risk of misleading 
information when the results are to be evaluated. Possibly the aspirate should be cleaned from 
bone spicules before injected in the tendon, to get better results. In short, there are several 
questions that need to be answered before more accurate conclusions can be drawn.   
 
Platelet rich plasma (PRP) seems to work similar to cell therapy as both aim to increase 
growth-factors. The high concentration of growth factors, especially in platelet a-granules, 
would in theory contribute to a better healing (McCarrel & Fortier, 2008). Sutter (2007) has 
investigated cell-based theories and states that PRP have shown to provide a provisional 
matrix which increase collagen I production, tenocytproliferation, neovascularization and also 
increase early strength, organization and fiber alignment. However, the PRP method lacks 
placebo-controlled studies in vivo even if the author mentions positive in vitro studies. The 
author discusses how the technique works and also how tendons in rats and humans have 
shown to heal better. But, he does not provide any actual results on healing suspensory 
ligament injuries with PRP on horses. 
 
Mc Carrel and Fortier (2008) compared the temporal release of growth-factors for PRP, PP 
and BMA and also measured their effect on ligament and tendon gene expression. They found 
that platelet concentration was highest in PRP and PP, and also that growth-factor 
concentration reflected platelet concentration. Hence – PRP and PP had the highest amount of 
growth factors. They also concluded that some growth factors in PRP even increased after 
contact with the tendon/ligament structures which would be optimal for ligament healing. 
However, the study is made in vitro and might not reflect the result of a suspensory ligament 
injury of a real case. Therefore, the authors now support in vivo studies with PRP and PP. 
 
Waselau et al. (2008) supports the injection of PRP together with controlled walking exercise. 
However, his study only contained nine horses and the low number of horses in the study 
makes it hard to evaluate whether PRP alone had any remarkable effect on the healing. If 
more horses had been used, including a control group with only conservative treated horses, 
the study would be more reliable.  
 
Dahlgren (2007) has summarized the pathobiology of tendon and ligament injuries in a review 
article. She states that injections with UBM are promising, at least in theory, and that it could 
provide a scaffold for cellular migration into the lesion, as well as organizing ECM and 
provide cell recruitment. She presents facts but has not made any studies herself. Wallis et al. 
(2010) seems to agree in theory, and as UBM has shown to increase angiogenesis in other 
species it would be relevant for healing ligaments. However, the study by Wallis showed no 
difference between the treated group and the control group on collagenase induced suspensory 
ligament injuries. The author concluded that UBM did not have a positive effect on the 
healing process. However, there is always a question of whether collagenase induced injuries 
is comparable to real cases or not.  
 
Since Shock-wave therapy generates high stress forces and act upon cellular interfaces 
(Gibson & Steel, 2002), it is on one hand believed to stimulate healing. On the other hand, it 
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“only” seems useful in some cases according to Dyson (2007). As the mechanisms are poorly 
understood, there is little fact to evaluate whether they could affect healing in a positive way. 
Both these articles discuss shock-wave therapy but have not made any studies on the method 
themselves.  
 
In the study by Imobden et al. (2007) it was concluded that one session of shock-wave 
therapy did not improve lameness. The study thus aimed at measuring lameness and did not 
take healing into consideration. It could thus be seen that shock-wave did not have any 
analgesic effect after only one session. It would, however, be interesting to see whether 
lameness improved after several treatments and also if healing was affected.  
 
The report that gives most support of the shock-wave therapy method, is the study by Chen et 
al. (2003). It shows that shock-wave treatment can promote healing of collagenase induced 
achilles-tendinitis in rats. The treatment induced growth factors TGF-b1 and IGF-1, both 
which have important roles in cell-proliferation and tissue regeneration in tendons. The results 
explain the mechanisms of shock-wave, but unfortunately the study is not performed on 
horses. The treated tendon (rats) does not have the same composition as the suspensory 
ligament and the injuries are collagenase induced.  
 
When discussing neuroectomy, it is important to note that the treatment only acts upon the 
symptom and not on the actual injury. The nerve innervating the area is removed and pain is 
lost. This is quite evident in the studies by Dyson & Genovese (2003) and Kelly (2007) as 
both have high scores in treating lameness (86% and 91% returning to full work). 
Unfortunately some information that could be used to evaluate the studies are missing.  Dyson 
& Genovese (2003) base their studies on “unpublished data” and “personal communication” 
from their own work. Whereas the study by Kelly (2007) have been demonstrated on an 
EVCS (European College of Veterinary Surgeons) meeting and information is limited. 
 
Furthermore, one shall not forget the possible negative consequences associated with this 
treatment such as neurogenic atrophy of the muscle fibers in the proximal parts of the 
suspensory ligament (Pauwels et al., 2009). If an area is not innervated, the surrounding 
muscles seem to get a gradual breakdown. This gives less support to the suspensory ligament 
and might predispose for new injuries. It should thus be noted that Pauwels et al, (2009) only 
had one horse in their study, which decrease the study’s credibility. 
 
In summary, we can conclude that more research within the area of injury, healing and 
treatment of suspensory ligament injuries is necessary. It is needed for an adequate 
understanding of the mechanisms of the disease and for the development of effective 
treatment methods.  
 
There is a general agreement of why the suspensory ligament in horses breaks. Healing 
mechanisms are also generally agreed on, judging from studies and reports on the subject. 
There are however contradictory findings of how to best treat the injuries. Researchers in the 
area agree on the fact that inflammation in the acute phase should be controlled. Also, the 
main purpose of later treatments is to promote new ECM, collagen I formation and alignment 
and prevent scar tissue from being abundant. Since no treatment alone has given any 
remarkable results in achieving this, this important area of study and research must be further 
explored.  
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